accountNew Pharma M&A Report First Quarter 2011 shows that Top 10 deals have been dominated by share buy backs: 6 of 10 deals and 69% of value!
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Does big pharma lack targets and investment opportunities?
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account